Literature DB >> 33845022

Classification Criteria for Multiple Sclerosis-Associated Intermediate Uveitis.

.   

Abstract

PURPOSE: The purpose of this study was to determine classification criteria for multiple sclerosis-associated intermediate uveitis.
DESIGN: Machine learning of cases with multiple sclerosis-associated intermediate uveitis and 4 other intermediate uveitides.
METHODS: Cases of intermediate uveitides were collected in an informatics-designed preliminary database, and a final database was constructed of cases achieving supermajority agreement on the diagnosis, using formal consensus techniques. Cases were split into a training set and a validation set. Machine learning using multinomial logistic regression was used in the training set to determine a parsimonious set of criteria that minimized the misclassification rate among the intermediate uveitides. The resulting criteria were evaluated in the validation set.
RESULTS: A total of 589 cases of intermediate uveitides, including 112 cases of multiple sclerosis-associated intermediate uveitis, were evaluated by machine learning. The overall accuracy for intermediate uveitides was 99.8% in the training set and 99.3% in the validation set (95% confidence interval: 96.1-99.9). Key criteria for multiple sclerosis-associated intermediate uveitis included unilateral or bilateral intermediate uveitis and multiple sclerosis diagnosed by the McDonald criteria. Key exclusions included syphilis and sarcoidosis. The misclassification rates for multiple sclerosis-associated intermediate uveitis were 0 % in the training set and 0% in the validation set.
CONCLUSIONS: The criteria for multiple sclerosis-associated intermediate uveitis had a low misclassification rate and appeared to perform sufficiently well enough for use in clinical and translational research.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33845022      PMCID: PMC8675393          DOI: 10.1016/j.ajo.2021.03.044

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.488


  28 in total

1.  Intermediate uveitis and multiple sclerosis: to scan or not to scan.

Authors:  Harry Petrushkin; Desmond Kidd; Carlos Pavesio
Journal:  Br J Ophthalmol       Date:  2015-09-02       Impact factor: 4.638

Review 2.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

Authors:  Alan J Thompson; Brenda L Banwell; Frederik Barkhof; William M Carroll; Timothy Coetzee; Giancarlo Comi; Jorge Correale; Franz Fazekas; Massimo Filippi; Mark S Freedman; Kazuo Fujihara; Steven L Galetta; Hans Peter Hartung; Ludwig Kappos; Fred D Lublin; Ruth Ann Marrie; Aaron E Miller; David H Miller; Xavier Montalban; Ellen M Mowry; Per Soelberg Sorensen; Mar Tintoré; Anthony L Traboulsee; Maria Trojano; Bernard M J Uitdehaag; Sandra Vukusic; Emmanuelle Waubant; Brian G Weinshenker; Stephen C Reingold; Jeffrey A Cohen
Journal:  Lancet Neurol       Date:  2017-12-21       Impact factor: 44.182

3.  No Value for Routine Serologic Screening for Borrelia burgdorferi in Patients With Uveitis in the Netherlands.

Authors:  Hawkar Kazi; Jolanda D F de Groot-Mijnes; Ninette H Ten Dam-van Loon; Jeannette Ossewaarde-van Norel; Jan Jelrik Oosterheert; Joke H de Boer
Journal:  Am J Ophthalmol       Date:  2016-04-11       Impact factor: 5.258

4.  Usefulness of Routine Lyme Screening in Patients with Uveitis.

Authors:  Sonny Caplash; Sapna Gangaputra; Natasha Kesav; Marib Akanda; Susan Vitale; Shilpa Kodati; Adriana Marques; H Nida Sen
Journal:  Ophthalmology       Date:  2019-06-27       Impact factor: 12.079

5.  Pars planitis: clinical features and class II HLA associations.

Authors:  S C Raja; D A Jabs; J P Dunn; S Fekrat; C H Machan; M J Marsh; N M Bressler
Journal:  Ophthalmology       Date:  1999-03       Impact factor: 12.079

6.  Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study.

Authors:  David C Gritz; Ira G Wong
Journal:  Ophthalmology       Date:  2004-03       Impact factor: 12.079

Review 7.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Authors:  Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

8.  The standardization of uveitis nomenclature project: the future is here.

Authors:  Annabelle A Okada; Douglas A Jabs
Journal:  JAMA Ophthalmol       Date:  2013-06       Impact factor: 7.389

9.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

10.  The prevalence of MS in the United States: A population-based estimate using health claims data.

Authors:  Mitchell T Wallin; William J Culpepper; Jonathan D Campbell; Lorene M Nelson; Annette Langer-Gould; Ruth Ann Marrie; Gary R Cutter; Wendy E Kaye; Laurie Wagner; Helen Tremlett; Stephen L Buka; Piyameth Dilokthornsakul; Barbara Topol; Lie H Chen; Nicholas G LaRocca
Journal:  Neurology       Date:  2019-02-15       Impact factor: 9.910

View more
  4 in total

Review 1.  A Comprehensive Update on Retinal Vasculitis: Etiologies, Manifestations and Treatments.

Authors:  Aniruddha Agarwal; Anne Rübsam; Lynn Zur Bonsen; Francesco Pichi; Piergiorgio Neri; Uwe Pleyer
Journal:  J Clin Med       Date:  2022-04-30       Impact factor: 4.964

2.  Classification Criteria For Pars Planitis.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-04-15       Impact factor: 5.488

3.  Development of Classification Criteria for the Uveitides.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-04-20       Impact factor: 5.488

Review 4.  [Development of classification criteria for uveitis by the standardization of uveitis nomenclature (SUN) working group].

Authors:  Arnd Heiligenhaus; Kai Rothaus; Uwe Pleyer
Journal:  Ophthalmologe       Date:  2021-08-30       Impact factor: 1.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.